Fidson Selected to Expand Influenza Treatment Access, Pandemic Preparedness - THISDAYLIVE

Fidson Healthcare Plc has been selected as one of eleven manufacturers across nine countries to sign sublicence agreements with the Medicines Patent Pool (MPP) for the development and manufacture of generic versions of baloxavir marboxil, an innovative antiviral treatment for influenza, under MPP’s voluntary licensing agreement with Roche. 

The Executive Director of the Medicines Patent Pool, Charles Gore, said: “We are now moving into implementation with manufacturers across multiple regions. This is exactly the kind of work that needs to happen before, rather than during, a health emergency. 

“We will now work closely with these manufacturers to support product development and regulatory approval, with the aim of making quality-assured generic baloxavir available as quickly as possible. By combining global manufacturing capacity with regionally focused production, we are helping build a more geographically diverse and resilient supply base for the future.”

The Vice President and Head of Global Policy, Roche, Tamara Schudel, remarked: “Moving from our initial agreement to actual sublicensing manufacturers today marks an important milestone and demonstrates what is possible when organisations lean in with trust, pragmatism, and a shared goal. It also demonstrates that voluntary partnerships are a critical pillar in pandemic preparedness enabling a rapid and effective response.” 

Founded on January 22, 1995, THISDAY is published by THISDAY NEWSPAPERS LTD., 35 Creek Road Apapa, Lagos, Nigeria with offices in 36 states of Nigeria , the Federal Capital Territory and around the world. It is Nigeria’s most authoritative news media available on all platforms for the political, business, professional and diplomatic elite and broader middle classes while serving as the meeting point of new ideas, culture and technology for the aspirationals and millennials. The newspaper is a public trust dedicated to the pursuit of truth and reason covering a range of issues from breaking news to politics, business, the markets, the arts, sports and community to the crossroads of people and society.

You can email us at: hello@thisdaylive.com or visit our contact us page.